Drugmakers look to use Purdue Pharma's bankruptcy to settle U.S. opioid suits, WSJ reports

Endo International Plc., Johnson & Johnson and other drugmakers that face litigation over the opioid crisis are exploring a way to settle the cases by participating in Purdue Pharma LP's bankruptcy, the Wall Street Journal reported, citing internal documents and a person familiar with the matter.